5 results
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... teaspoons) 1-4 times ... aspiration #Potassium #Binding ... #pharmacology #table ... #comparison #binders
Rapid, increasing signs of extrapyramidal symptoms (EPS) is an important key feature of NMS. EPS, associated
important key feature ... about 95% of NMS cases ... Laboratory findings ... NeurolepticMalignant #Comparison ... #Table
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Weakness, cramping, nausea ... only if no clear cause ... Elimination (see Table ... Treatments: • K-Binding ... failure of other measures
Sarcoidosis - Diagnosis and Management Summary
Epidemiology
1) High incidence in Scandinavian countries (11-24 cases per 100,000 individuals
hyperphosphatemia, hypercalcemia ... failure Clinical Features ... symptoms are not caused ... symptoms at the time ... incidental CXR finding
Premature Ventricular Complexes (PVC's) - Summary Framework

Why PVCs?  Can be the first manifestation of cardiac
heart disease Causes ... Hypomagnesemia • Hypokalemia ... = NSVT EKG Findings ... as NSVT until a time ... tachyarrhythmias High-risk features